Skip to main content

Fourth scientific day, IVF and ICSI unit at Women's Health University Hospital

اليوم العلمي الرابع

       وحدة الاخصاب المساعد والحقن المجهري

             بمستشفي صحة المرأة الجامعي

 تحت رعاية

ا. د/ طارق الجمال    رئيس الجامعة

ا. د/ علاء عطيه        عميد كلية الطب ورئيس مجلس إدارة المستشفيات

 ا. د/ إيهاب فوزي    المدير التنفيذي للمستشفيات الجامعية

ا. د/ أحمد فائق       مدير المستشفى.

 عن الجديد في مجال العقم والحقن المجهري .. في اليوم العلمي الرابع لوحدة الاخصاب المساعد بمستشفى صحة المرأة الجامعي.

بحضور نخبة من السادة اعضاء هيئة التدريس

واليوم ٤ محاضرات علمية مثمرة حاضر فيها:

 ا. د/ محمد علي بديوي أستاذ بجامعة فانكوفر بكندا

ا. د/ طارق خلف الحسيني أستاذ النساء والتوليد والحقن المجهري بكلية الطب جامعة أسيوط

د/ رضا الشريف مدرس بقسم النساء والتوليد والحقن المجهري بكلية الطب جامعة أسيوط.

وقد اهدي ا. د/ سيد عبد الحميد  شهادة تكريم وعرفان بالنيابة عن القسم والوحدة للاستاذ الدكتور/ لدوره ومجهوده المميز للوحدة.

1345678910111

Congratulations on winning the ideal doctor (underage) - from the Assiut Physicians Syndicate

أ. د/علاء عطية عميد كلية الطب ورئيس مجلس إدارة المستشفيات الجامعية.

أ. د/ اماني عمر وكيل الكلية لشئون التعليم والطلاب

أ. د/ يوسف صالح وكيل الكلية لشئون الدراسات العليا والبحوث

أ. د/ سعد زكي محمود وكيل الكلية لشئون خدمة المجتمع وتنمية البيئة.

                             يهنئون

                      د/ ادريس حسن

                     استشاري طب الاطفال

        ومدير المركز العلمي م الاطفال الجامعي

           مدير الجودة في م الجامعي الرئيسي

بفوزه بالطبيب المثالي (تحت السن) من نقابة أطباء اسيوط.

Congratulations to the Cardiothoracic Surgery Team - Assiut University

أ. د/علاء عطية عميد كلية الطب ورئيس مجلس إدارة المستشفيات الجامعية.

أ. د/ اماني عمر وكيل الكلية لشئون التعليم والطلاب

أ. د/ يوسف صالح وكيل الكلية لشئون الدراسات العليا والبحوث

أ. د/ سعد زكي محمود وكيل الكلية لشئون خدمة المجتمع وتنمية البيئة.

                            يهنئون

    فريق جراحة القلب والصدر بجامعة اسيوط

تكريمهم في يوم الطبيب (اطباء متميزون) من النقابة العامة لأطباء مصر.

Announcement of an introductory lecture on the agreement of the Egyptian Knowledge Bank for open publication with Springer Nature Foundation

 

Dear EKB User

 

We would like to invite you to join the Summit titled Open Access for Egypt on March 15th planned by Springer Nature in collaboration with Egyptian knowledge bank and STDF.

 

More than 150 Egyptian institutions are participating in the Transformative Agreement between Springer Nature and Science, Technology & Innovation Funding Authority (STDF) in cooperation with Egyptian Knowledge Bank (EKB). This means, from 01 January 2022, corresponding authors affiliated with these institutions are eligible to publish their articles OA with fees covered if a majority of the research is carried out at a participating Egyptian institution. The agreement is a Transformative Agreement plus fully OA Agreement, and includes more than 2,400 journals across the Springer Nature portfolio.

 

If you are a corresponding author affiliated with a participating Egyptian institution, you may be eligible to publish open access (OA) in our journals with fees covered under a Transformative Agreement plus fully OA agreement. This agreement will cover all the public, private and national universities, as well as the research centers related to the ministry of higher education and scientific research and all other governmental ministries in Egypt.

 

 

Agenda:

10:15 - 10:30: Welcome and Introductions

10:30 - 11:00 10:30 - 11:00: Welcome and Springer Nature Transformative Agreement Update /Country Overview

Asdaa Kotani -  Vice President Institutional Sales EMEA

11:00 - 11:30 11:00 - 11:30: Welcome EKB - STDF - Why Funding Researchers in Egypt for OA Session

The Science, Technology & Innovation Funding Authority (STDF)

11:30 - 12:00:  Why Open Access with Springer Nature

Leen Samarah - Account Development Manager Middle East

12:00 – 12:15 Break

12:15 – 13:15 How to Publish with Springer Nature

Ties Nijssen -  Executive Editor Humanities and Social Sciences

13:15 - 13:45: Once you are approved to publish with a Springer Nature journal how to apply for OA funding by STDF

Patrick Wakelam -  Implementation Manager Open Research Strategy  

13:45 - 14:15                    

13:45 - 14:15: Q&A and Wrap up

 

Session Link:

 

https://bit.ly/3hkNKbk

 

Looking forward to welcoming you

Evaluation of the scolicidal activities of eugenol essential oil and its nanoemulsion against protoscoleces of hydatid cysts

Research Abstract

Abstract
Background
Cystic echinococcosis caused by the cestode Echinococcus granulosus remains a serious
helminthic zoonosis affecting humans and animals in many endemic developing countries.
Surgical intervention is the best management choice, although it is associated with high
recurrence rates and serious complications. Also, the commonly used chemotherapeutics
exhibited serious side effects. This study aimed to evaluate the protoscolicidal effects of
eugenol (Eug) essential oil and its nanoemulsion (Eug-NE) against protoscoleces (PCs) of
hydatid cysts in vitro.
Methods
Eug-NE was prepared and characterized. Their cytotoxicity on macrophages was assessed
by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. E. granulosus
PCs were treated with various concentrations of Eug and Eug-NE at different exposure
times. The viability of protoscoleces was evaluated by the eosin exclusion test, and the
changes in the morphology of protoscoleces were assessed. Albendazole (ABZ) was used
as a positive control.
Results
The cellular cytotoxicity of Eug and Eug-NE on macrophage cells, in minimum and maximum
concentrations (0.2 and 1 μl/mL), were nearly negligible ranging from 4.7% to 8.3%
and 3.7% to 7.2%, respectively. The results showed highly significant activity of Eug-NE and
Eug against hydatid PCs compared to ABZ (P < 0.05). Eug and Eug-NE have similar protoscolicidal
effects at all used concentrations. Their highest scolicidal activity (100% mortality
rate) was recorded at 1 μl/ml after 30 min incubation (LC50 = 0.298—LC90 = 0.521 and LC50
= 0.309—LC90 = 0.646, respectively). Both formulations showed time- and dose-dependent
effects.

Research Authors
Maria Naged Maurice, Enas Abdelhameed Mahmoud Huseein, Mohamed El-Salahy M. M. Monib, Fahd M. Alsharif, Nader Ibrahim Namazi, Alzahraa Abdelraouf Ahmad
Research Date
Research Department
Research Journal
PLOS ONE
Research Pages
e0259290.
Research Publisher
PLOS ONE
Research Vol
16
Research Website
https://doi.org/10.1371/journal. pone.0259290
Research Year
2021

Prevalence of occult hepatitis C virus in patients with HCV - antibody positivity and serum HCV RNA negativity

Research Authors
HA Aboalam , HAG Rashed, MA Mekky, HM Nafeh, OA Osman
Research Date
Research Journal
Journal of Current Medical Research and Practice
Research Pages
12
Research Vol
1 (2)
Research Year
2016

Effect of Etonogestrel contraceptive implant(Implanon ) on portal blood flow and liver functions

Research Authors
A Nasr , H M Nafeh
Research Date
Research Journal
Contraception
Research Pages
236 - 239
Research Vol
79 (3)
Research Year
2009
Subscribe to